{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:29:07Z","timestamp":1790076547079,"version":"4.0.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.pt.2019.11.005","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T22:58:48Z","timestamp":1576709928000},"page":"195-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Advances in Vaccine Development for Human Lymphatic Filariasis"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2202-9245","authenticated-orcid":false,"given":"Ramaswamy","family":"Kalyanasundaram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2019.11.005_bib1","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.pt.2019.08.003","article-title":"Evaluating the evidence for lymphatic filariasis elimination","volume":"35","author":"Davis","year":"2019","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2019.11.005_bib2","doi-asserted-by":"crossref","first-page":"e3328","DOI":"10.1371\/journal.pntd.0003328","article-title":"Global programme to eliminate lymphatic filariasis: the processes underlying programme success","volume":"8","author":"Ichimori","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2019.11.005_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40249-019-0520-1","article-title":"Potential factors influencing lymphatic filariasis transmission in 'hotspot' and 'control' areas in Ghana: the importance of vectors","volume":"8","author":"Pi-Bansa","year":"2019","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.pt.2019.11.005_bib4","doi-asserted-by":"crossref","first-page":"eaau2086","DOI":"10.1126\/scitranslmed.aau2086","article-title":"Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis","volume":"11","author":"Taylor","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.pt.2019.11.005_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-3024.2011.01350.x","article-title":"Future prospects and challenges of vaccines against filariasis","volume":"34","author":"Babayan","year":"2012","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.pt.2019.11.005_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1128\/CMR.00002-13","article-title":"A comprehensive, model-based review of vaccine and repeat infection trials for filariasis","volume":"26","author":"Morris","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.pt.2019.11.005_bib7","series-title":"Lymphatic Filariasis","first-page":"59","article-title":"Next step lymphatic filariasis eradication: current status in the development of a vaccine against lymphatic filariasis","author":"Kalyanasundaram","year":"2018"},{"key":"10.1016\/j.pt.2019.11.005_bib8","first-page":"81","article-title":"Vaccination greatly reduces disease, disability, death and inequity worldwide","volume":"86","author":"Andre","year":"2008","journal-title":"WHO Bull."},{"key":"10.1016\/j.pt.2019.11.005_bib9","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1084\/jem.191.4.731","article-title":"B1 B lymphocytes play a critical role in host protection against lymphatic filarial parasites","volume":"191","author":"Paciorkowski","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.pt.2019.11.005_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/pim.12081","article-title":"Immunology of lymphatic filariasis","volume":"36","author":"Babu","year":"2014","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.pt.2019.11.005_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00430-002-0157-7","article-title":"Protective immunity in human lymphatic filariasis: problems and prospects","volume":"192","author":"Ravindran","year":"2003","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.pt.2019.11.005_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/B978-0-12-374279-7.13014-0","article-title":"Immunology of lymphatic filariasis","volume":"4","author":"Nutman","year":"2016","journal-title":"Encyclopedia Immunobiol."},{"key":"10.1016\/j.pt.2019.11.005_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2013.00305","article-title":"Regulatory T\u00a0cell subsets in filarial infection and their function","volume":"4","author":"Metenou","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pt.2019.11.005_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri2992","article-title":"Diversity and dialogue in immunity to helminths","volume":"11","author":"Allen","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.pt.2019.11.005_bib15","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1128\/IAI.67.11.5951-5957.1999","article-title":"Human onchocerciasis and tetanus vaccination: impact on the post vaccination anti-tetanus antibody response","volume":"67","author":"Cooper","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2019.11.005_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/sji.12533","article-title":"Immunity in filarial infections: lessons from animal models and human studies","volume":"85","author":"Kwarteng","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.pt.2019.11.005_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0169-4758(91)90215-A","article-title":"The endemic normal in lymphatic filariasis: a static concept","volume":"7","author":"Day","year":"1991","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.pt.2019.11.005_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1086\/321004","article-title":"Evolution of immunologic responsiveness of persons living in an area of endemic bancroftian filariasis: a 17-year follow-up","volume":"184","author":"Steel","year":"2001","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.pt.2019.11.005_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-3024.2000.00280.x","article-title":"Human antibody responses to Wuchereria bancrofti infective larvae","volume":"22","author":"Helmy","year":"2000","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.pt.2019.11.005_bib20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0035-9203(82)90191-2","article-title":"Immune responses in human Brugia malayi infections: serum dependent cell-mediated destruction of infective larvae in\u00a0vitro","volume":"76","author":"Sim","year":"1982","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2019.11.005_bib21","series-title":"The Filaria","first-page":"109","article-title":"Immune effectors important in protective resistance","author":"Hoerauf","year":"2002"},{"key":"10.1016\/j.pt.2019.11.005_bib22","first-page":"1","article-title":"Lymphatic filariasis: current status of elimination using chemotherapy and the need for a vaccine","volume":"vol. 29","author":"Kalyanasundaram","year":"2016"},{"key":"10.1016\/j.pt.2019.11.005_bib23","first-page":"289","article-title":"Differential recognition of microfilarial chitinase, a transmission-blocking vaccine candidate antigen, by sera from patients with Brugian and Bancroftian filariasis","volume":"53","author":"Dissanayake","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2019.11.005_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4269\/ajtmh.2009.80.319","article-title":"Evaluation of immunoprophylactic efficacy of Brugia malayi transglutaminase (BmTGA) in single and multiple antigen vaccination with BmALT-2 and BmTPX for human lymphatic filariasis","volume":"80","author":"Vanam","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2019.11.005_bib25","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.1371\/journal.pntd.0000457","article-title":"Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis","volume":"3","author":"Veerapathran","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2019.11.005_bib26","doi-asserted-by":"crossref","first-page":"e72585","DOI":"10.1371\/journal.pone.0072585","article-title":"Immunization of Mastomys coucha with Brugia malayi recombinant trehalose-6-phosphate phosphatase results in significant protection against homologous challenge infection","volume":"8","author":"Kushwa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2019.11.005_bib27","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.vaccine.2014.01.064","article-title":"Disorganized muscle protein-1 (DIM-1) of filarial parasite Brugia malayi: cDNA cloning, expression, purification, structural modeling and its potential as vaccine candidate for human filarial infection","volume":"32","author":"Kushwaha","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2019.11.005_bib28","doi-asserted-by":"crossref","first-page":"e0006772","DOI":"10.1371\/journal.pntd.0006772","article-title":"Ligand binding properties of two Brugia malayi fatty acid and retinol (FAR) binding proteins and their vaccine efficacies against challenge infection in gerbils","volume":"12","author":"Zhan","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2019.11.005_bib29","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1016\/j.vaccine.2017.07.105","article-title":"Recombinant Calponin of human filariid Brugia malayi: secondary structure and immunoprophylactic potential","volume":"35","author":"Verma","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2019.11.005_bib30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1017\/S0022149X13000333","article-title":"Tandem antioxidant enzymes confer synergistic protective responses in experimental filariasis","volume":"88","author":"Prince","year":"2014","journal-title":"J.\u00a0Helminthol."},{"key":"10.1016\/j.pt.2019.11.005_bib31","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s12026-017-8911-5","article-title":"Immunoprophylaxis of multi-antigen peptide (MAP) vaccine for human lymphatic filariasis","volume":"65","author":"Immanuel","year":"2017","journal-title":"Immunol. Res."},{"key":"10.1016\/j.pt.2019.11.005_bib32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cimid.2013.05.003","article-title":"Immunization with a multisubunit vaccine considerably reduces establishment of 639 infective larvae in a rodent model of Brugia malayi","volume":"36","author":"Shrivastava","year":"2013","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.pt.2019.11.005_bib33","first-page":"45","article-title":"Multivalent vaccine formulation with BmVAL-1 and BmALT-2 confer significant protection against challenge infections with Brugia malayi in mice and jirds","volume":"2","author":"Kalyanasundaram","year":"2011","journal-title":"Res. Rep. Trop. Med."},{"key":"10.1016\/j.pt.2019.11.005_bib34","doi-asserted-by":"crossref","first-page":"e0004586","DOI":"10.1371\/journal.pntd.0004586","article-title":"Vaccination of gerbils with Bm-103 and Bm-RAL-2 concurrently or as a fusion protein confers consistent and improved protection against Brugia malayi infection","volume":"10","author":"Arumugam","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2019.11.005_bib35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1017\/S0022149X16000055","article-title":"Epitope mapping of Brugia malayi ALT-2 and the development of a multi-epitope vaccine for lymphatic filariasis","volume":"91","author":"Madhumathi","year":"2017","journal-title":"J.\u00a0Helminthol."},{"key":"10.1016\/j.pt.2019.11.005_bib36","first-page":"493","article-title":"Studies on immunization against Brugia malayi infection in the rhesus monkey","volume":"40","author":"Wong","year":"1969","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.pt.2019.11.005_bib37","doi-asserted-by":"crossref","first-page":"e112982","DOI":"10.1371\/journal.pone.0112982","article-title":"Evaluation of a multivalent vaccine against lymphatic filariasis in rhesus macaque model","volume":"9","author":"Dakshinamoorthy","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2019.11.005_bib38","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ijpara.2018.04.002","article-title":"Prospects of developing a prophylactic vaccine against human lymphatic filariasis \u2013 evaluation of protection in non-human primates","volume":"48","author":"Khatri","year":"2018","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.pt.2019.11.005_bib39","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.vetpar.2011.04.041","article-title":"Detection of human filarial parasite Brugia malayi in dogs by histochemical staining and molecular techniques","volume":"181","author":"Ambily","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.pt.2019.11.005_bib40","doi-asserted-by":"crossref","first-page":"630160","DOI":"10.1155\/2014\/630160","article-title":"Canine filarial infections in a human Brugia malayi endemic area of India","volume":"2014","author":"Ravindran","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.pt.2019.11.005_bib41","doi-asserted-by":"crossref","first-page":"E44","DOI":"10.3390\/tropicalmed4010044","article-title":"The global burden of disease of zoonotic parasitic diseases: top 5 contenders for priority consideration","volume":"4","author":"Pisarski","year":"2019","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.pt.2019.11.005_bib42","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0169-4758(91)90270-X","article-title":"A model for the dynamics of human lymphatic filariasis","volume":"7","author":"Grenfell","year":"1991","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.pt.2019.11.005_bib43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0035-9203(02)90224-5","article-title":"The Brugia malayi genome project: expressed sequence tags and gene discovery","volume":"96","author":"Blaxter","year":"2002","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2019.11.005_bib44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.meegid.2012.11.002","article-title":"Inter and intra-specific diversity of parasites that cause lymphatic filariasis","volume":"14","author":"McNulty","year":"2013","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.pt.2019.11.005_bib45","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1074\/mcp.M114.038539","article-title":"Comparative analysis of the secretome from a model filarial nematode (Litomosoides sigmodontis) reveals maximal diversity in gravid female parasites","volume":"13","author":"Armstrong","year":"2014","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.pt.2019.11.005_bib46","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.vaccine.2012.09.055","article-title":"Multivalent fusion protein vaccine for lymphatic filariasis","volume":"31","author":"Dakshinamoorthy","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2019.11.005_bib47","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1128\/IAI.72.8.4707-4715.2004","article-title":"Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi","volume":"72","author":"Gnanasekar","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2019.11.005_bib48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4269\/ajtmh.1991.44.161","article-title":"Analysis of isotype-specific antifilarial antibody levels in a Haitian pediatric population","volume":"44","author":"Hitch","year":"1991","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2019.11.005_bib49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4269\/ajtmh.2006.75.97","article-title":"Filarial-specific antibody response in East African bancroftian filariasis: effects of host infection, clinical disease, and filarial endemicity","volume":"75","author":"Jaoko","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2019.11.005_bib50","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/IAI.68.7.4174-4179.2000","article-title":"The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis","volume":"68","author":"Gregory","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.pt.2019.11.005_bib51","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.actatropica.2008.04.018","article-title":"Comparison of immunogenicity, protective efficacy of single and cocktail DNA vaccine of Brugia malayi abundant larval transcript (ALT-2) and thioredoxin peroxidase (TPX) in mice","volume":"107","author":"Anand","year":"2008","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2019.11.005_bib52","doi-asserted-by":"crossref","first-page":"e77394","DOI":"10.1371\/journal.pone.0077394","article-title":"Large extracellular loop of tetraspanin as a potential vaccine candidate for filariasis","volume":"8","author":"Dakshinamoorthy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2019.11.005_bib53","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0022149X10000799","article-title":"A combination of two Brugia malayi filarial vaccine candidate antigens (BmALT-2 and BmVAH) enhances immune responses and protection in jirds","volume":"85","author":"Anand","year":"2011","journal-title":"J.\u00a0Helminth."},{"key":"10.1016\/j.pt.2019.11.005_bib54","doi-asserted-by":"crossref","first-page":"e34077","DOI":"10.1371\/journal.pone.0034077","article-title":"Biochemical characterization and evaluation of a Brugia malayi small heat shock protein as a vaccine against lymphatic filariasis","volume":"7","author":"Dakshinamoorthy","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pt.2019.11.005_bib55","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.1371\/journal.pntd.0000457","article-title":"Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis","volume":"3","author":"Veerapathran","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2019.11.005_bib56","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.vaccine.2016.03.112","article-title":"Human anthelminthic vaccines: rationale and challenges","volume":"34","author":"Hotez","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2019.11.005_bib57","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/sji.12340","article-title":"Chimeric epitope vaccine from multistage antigens for lymphatic filariasis","volume":"82","author":"Anugraha","year":"2015","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.pt.2019.11.005_bib58","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1038\/s41598-019-40833-x","article-title":"In-silico design of a multi-epitope vaccine candidate against onchocerciasis and related filarial diseases","volume":"9","author":"Shey","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pt.2019.11.005_bib59","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.3389\/fimmu.2018.01520","article-title":"Evaluating the vaccine potential of a tetravalent fusion protein (rBmHAXT) vaccine antigen against lymphatic filariasis in a mouse model","volume":"9","author":"Chauhan","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pt.2019.11.005_bib60","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/10826068.2018.1514511","article-title":"Cloning, large-scale production and characterization of fusion protein (P-TUFT-ALT-2) of Brugian abundant larval transcript-2 with tuftsin in Pichia pastoris","volume":"48","author":"Paul","year":"2018","journal-title":"Prep. Biochem. Biotechnol."},{"key":"10.1016\/j.pt.2019.11.005_bib61","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s00436-017-5593-9","article-title":"Improving the efficacy of a prophylactic vaccine formulation against lymphatic filariasis","volume":"116","author":"Chauhan","year":"2017","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.pt.2019.11.005_bib62","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.biotechadv.2013.12.006","article-title":"Genome- and proteome-wide screening strategies for antigen discovery and immunogen design","volume":"32","author":"Schussek","year":"2014","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.pt.2019.11.005_bib63","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/vaccines7040122","article-title":"Enlisting the mRNA vaccine platform to combat parasitic infections","volume":"7","author":"Versteeg","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.pt.2019.11.005_bib64","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1471-2164-13-184","article-title":"Transcription profiling reveals stage- and function-dependent expression patterns in the filarial nematode Brugia malayi","volume":"13","author":"Li","year":"2012","journal-title":"BMC Genom."},{"key":"10.1016\/j.pt.2019.11.005_bib65","series-title":"The Filaria","first-page":"167","article-title":"Vaccines for filarial infections","author":"Keiser","year":"2002"},{"key":"10.1016\/j.pt.2019.11.005_bib66","series-title":"Lymphatic Filariasis: Epidemiology, Clinical Manifestations, and Diagnosis","first-page":"2019","author":"Klion","year":"2019"},{"key":"10.1016\/j.pt.2019.11.005_bib67","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pt.2006.03.005","article-title":"Mathematical models and lymphatic filariasis control: endpoints and optimal interventions","volume":"22","author":"Michael","year":"2006","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2019.11.005_bib68","article-title":"The health and economic burden of lymphatic filariasis prior to mass drug administration programmes","author":"Mathew","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2019.11.005_bib69","doi-asserted-by":"crossref","first-page":"e0007325","DOI":"10.1371\/journal.pntd.0007325","article-title":"Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Cote d'Ivoire","volume":"13","author":"Edi","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2019.11.005_bib70","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40249-019-0578-9","article-title":"Lessons from lymphatic filariasis elimination and the challenges of post-elimination surveillance in China","volume":"8","author":"Fang","year":"2019","journal-title":"Infect. Dis. Poverty"},{"key":"10.1016\/j.pt.2019.11.005_bib71","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00436-019-06316-8","article-title":"Troponin 1 of human filarial parasite Brugia malayi: cDNA cloning, expression, purification, and its immunoprophylactic potential","volume":"118","author":"Kushwaha","year":"2019","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.pt.2019.11.005_bib72","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00436-019-06318-6","article-title":"CpG enhances the immunogenicity of heterologous DNA-prime\/protein-boost vaccination with the heavy chain myosin of Brugia malayi in BALB\/c mice","volume":"118","author":"Gupta","year":"2019","journal-title":"Parasitol. Res."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492219302806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492219302806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:36:54Z","timestamp":1761464214000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492219302806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1471492219302806"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2019.11.005","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Vaccine Development for Human Lymphatic Filariasis","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2019.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}